middle.news
Bioxyne Ltd H1 FY26 Revenue Surges 149% on Medicinal Cannabis and Psychedelic Demand
9:58am on Thursday 26th of February, 2026 AEDT
•
Pharmaceuticals
Read Story
Bioxyne Ltd H1 FY26 Revenue Surges 149% on Medicinal Cannabis and Psychedelic Demand
9:58am on Thursday 26th of February, 2026 AEDT
Key Points
Revenue jumps 149% to $31.3 million in H1 FY26
Net profit after tax rises 126% to $7.3 million
Expanded manufacturing capacity and international market entry
Dual listing completed on Frankfurt Stock Exchange
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
BIOXYNE (ASX:BXN)
OPEN ARTICLE